Literature DB >> 20824437

Rare diseases epidemiology research.

Manuel Posada de la Paz1, Ana Villaverde-Hueso, Verónica Alonso, Sándor János, Oscar Zurriaga, Marina Pollán, Ignacio Abaitua-Borda.   

Abstract

Rare Diseases Epidemiology is a novel action field still largely unexplored. However, Rare Diseases is a topic of growing interest at world level. The aims of this chapter are to revise useful epidemiological tools and define areas where epidemiology can help improve the rare disease knowledge, and facilitate policy decisions taking into account the real burden of rare diseases in society. This chapter also seeks to describe: the problems of coding and classification of diseases, measuring disease frequency, the study designs and association studies, the causality, the evolution from descriptive to epigenetic epidemiology and the natural history of disease. One of the major challenges facing analytical epidemiology and clinical epidemiological research into rare diseases is that genes can be involved in both aetiology and prognosis. Despite the many similarities between genetic association studies and classic observational epidemiological studies, the former pose several specific limitations, including an unprecedented volume of new data and the likelihood of very small individual effects, as well other limitations. Selecting the appropriate pathway from among all those available, i.e. the one that best relates genes from the various known regions and disease mechanisms, is crucial for the success of this type of studies.

Mesh:

Year:  2010        PMID: 20824437     DOI: 10.1007/978-90-481-9485-8_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  28 in total

1.  Natural history of diseases: Statistical designs and issues.

Authors:  Nicholas P Jewell
Journal:  Clin Pharmacol Ther       Date:  2016-08-18       Impact factor: 6.875

2.  The incidence of inherited porphyrias in Europe.

Authors:  George Elder; Pauline Harper; Michael Badminton; Sverre Sandberg; Jean-Charles Deybach
Journal:  J Inherit Metab Dis       Date:  2012-11-01       Impact factor: 4.982

3.  The Italian National Rare Diseases Registry.

Authors:  Domenica Taruscio; Yllka Kodra; Gianluca Ferrari; Luciano Vittozzi
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

4.  Using inpatient data to estimate the prevalence of Wegener's granulomatosis in China.

Authors:  Xiao Liu; Yazhou Cui; Yan Li; Chao Wang; Heng Zhao; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2016-02

Review 5.  Modeling rare diseases with induced pluripotent stem cell technology.

Authors:  Ruthellen H Anderson; Kevin R Francis
Journal:  Mol Cell Probes       Date:  2018-01-05       Impact factor: 2.365

6.  Emerging Genetic Counselor Roles within the Biotechnology and Pharmaceutical Industries: as Industry Interest Grows in Rare Genetic Disorders, How are Genetic Counselors Joining the Discussion?

Authors:  Tessa Field; Stephanie Jo Brewster; Meghan Towne; MaryAnn W Campion
Journal:  J Genet Couns       Date:  2016-03-28       Impact factor: 2.537

Review 7.  Risk of malignancy associated with head and neck CT in children: a systematic review.

Authors:  Jenny X Chen; Bart Kachniarz; Sapideh Gilani; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-07-22       Impact factor: 3.497

8.  Tissue Chips to aid drug development and modeling for rare diseases.

Authors:  Lucie A Low; Danilo A Tagle
Journal:  Expert Opin Orphan Drugs       Date:  2016-10-19       Impact factor: 0.694

9.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

10.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.